Sotera Health Co (SHC) shareholders
Close on Nov 16, 2026Market cap $4.64BP/E 28.5Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Warburg Pincus Xi-C, LLC. Joint filing with WP XI Partners, L.P. (36.30%), Warburg Pincus Private Equity Xi, L.P. (36.30%) and 13 more | 103,038,253 | 36.30% | 13G (passive) amendment | Sep 5, 2025 |
| Gtcr Fund Xi/C LP Joint filing with Gtcr Investment Xi LLC (36.30%), Gtcr Fund Xi/A LP (36.30%) and 2 more | 103,038,253 | 36.30% | 13G (passive) amendment | Sep 5, 2025 |
| Wp Global LLC Joint filing with WP XI Partners, L.P. (25.70%), Warburg Pincus Private Equity Xi, L.P. (25.70%) and 13 more | 73,038,253 | 25.70% | 13G (passive) amendment | Nov 10, 2025 |
| Gtcr Investment Xi LLC Joint filing with Gtcr Fund Xi/A LP (20.00%), Gtcr Fund Xi/C LP (20.00%) and 2 more | 56,838,253 | 20.00% | 13G (passive) amendment | Dec 3, 2025 |
| Warburg Pincus & Co. Joint filing with WP XI Partners, L.P. (11.20%), Warburg Pincus Private Equity XI, L.P. (11.20%) and 13 more | 31,838,253 | 11.20% | 13G (passive) amendment | Mar 6, 2026 |
| Gtcr Partners Xi/A&c LP Joint filing with Gtcr Fund Xi/C LP (11.20%), Gtcr Co-Invest Xi LP (11.20%) and 2 more | 31,838,253 | 11.20% | 13G (passive) amendment | Mar 6, 2026 |
| Sessa Capital IM, L.P. Joint filing with John Petry (9.50%) | 27,050,000 | 9.50% | 13G (passive) amendment | Jun 30, 2026 |
| Darsana Capital GP LLC Joint filing with Darsana Capital Partners LP (8.80%), Darsana Capital Partners GP LLC (8.80%) and 2 more | 25,000,000 | 8.80% | 13G (passive) amendment | Sep 30, 2025 |
| Sculptor Capital LP Joint filing with Sculptor Capital II LP (8.41%), Sculptor Capital Holding Corp (8.41%) and 3 more | 24,000,000 | 8.41% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 23,845,504 | 8.40% | 13G (passive) amendment | Jun 30, 2026 |
| Sculptor Capital Holding Corp Joint filing with Sculptor Capital LP (7.39%), Sculptor Capital II LP (7.39%) and 3 more | 21,000,000 | 7.39% | 13G (passive) amendment | Dec 31, 2025 |
| John Petry Joint filing with Sessa Capital GP, LLC (7.23%), Sessa Capital IM, L.P. (7.23%) and 2 more | 20,550,000 | 7.23% | 13G (passive) | Dec 31, 2025 |
| Ferguson Scott D. Joint filing with Sachem Head Capital Management LP (5.46%), Uncas GP LLC (5.46%) | 15,560,000 | 5.46% | 13G (passive) | May 11, 2026 |
| Sculptor Capital II LP Joint filing with Sculptor Capital LP (5.19%), Sculptor Capital Holding Corp (5.19%) and 3 more | 14,750,000 | 5.19% | 13G (passive) | Sep 4, 2025 |
| Vanguard Capital Management | 14,625,165 | 5.12% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sessa Capital IM, L.P. | 27,050,000 | 9.48% | $480.14M | +4,000,000 | 8.03% |
| Darsana Capital Partners LP | 27,000,000 | 9.46% | $479.25M | +1,000,000 | 2.15% |
| BlackRock, Inc. | 24,148,424 | 8.46% | $428.63M | +3,298,845 | 0.01% |
| Sculptor Capital LP | 24,000,000 | 8.41% | $426.00M | +2,282,272 | 3.47% |
| Sachem Head Capital Management LP | 15,560,000 | 5.45% | $276.19M | +3,915,000 | 5.73% |
| Vanguard Capital Management LLC | 12,170,699 | 4.26% | $216.03M | +1,435,693 | 0.00% |
| Vanguard Portfolio Management LLC | 11,946,341 | 4.19% | $212.05M | +1,337,624 | 0.01% |
| Aqr Capital Management LLC | 10,734,313 | 3.76% | $186.40M | +4,013,550 | 0.06% |
| T. Rowe Price Investment Management, Inc. | 10,518,373 | 3.69% | $186.70M | +1,392,752 | 0.12% |
| Jupiter Topco LLC | 8,402,106 | 2.94% | $149.14M | New | 0.06% |
| State Street Corp | 8,324,321 | 2.92% | $147.76M | +1,302,695 | 0.00% |
| FMR LLC | 6,173,320 | 2.16% | $109.58M | +6,144,727 | 0.00% |
| Two Seas Capital LP | 5,836,053 | 2.05% | $103.59M | −187,318 | 2.05% |
| Voss Capital, LLC | 5,825,000 | 2.04% | $103.39M | +953,730 | 4.80% |
| Dimensional Fund Advisors LP | 5,799,870 | 2.03% | $102.94M | +280,995 | 0.02% |
| Geode Capital Management, LLC | 5,219,965 | 1.83% | $92.68M | +580,066 | 0.00% |
| Irenic Capital Management LP | 5,141,822 | 1.80% | $91.27M | +782,474 | 4.38% |
| DME Capital Management, LP | 4,135,515 | 1.45% | $73.41M | +2,069,835 | 1.88% |
| Lakewood Capital Management, LP | 3,979,581 | 1.39% | $70.64M | −125,000 | 3.64% |
| Norges Bank | 3,512,499 | 1.23% | $62.35M | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 319 | 295M | 100.0% | 60 / 165 | 65 / 35 | 73M | 46M |
| Q1 2026 | 299 | 276M | 96.8% | 60 / 147 | 60 / 39 | 67M | 36M |
| Q4 2025 | 285 | 267M | 93.4% | 78 / 145 | 39 / 34 | 58M | 54M |
| Q3 2025 | 244 | 264M | 92.6% | 50 / 116 | 49 / 28 | 22M | 30M |
| Q2 2025 | 223 | 272M | 95.2% | 49 / 103 | 49 / 30 | 14M | 13M |
| Q1 2025 | 205 | 271M | 94.8% | 26 / 66 | 75 / 35 | 16M | 10M |
| Q4 2024 | 216 | 264M | 92.6% | 39 / 88 | 58 / 31 | 19M | 20M |
| Q3 2024 | 209 | 266M | 93.2% | 33 / 101 | 45 / 27 | 49M | 35M |
| Q2 2024 | 204 | 263M | 92.2% | 40 / 73 | 63 / 31 | 13M | 14M |
| Q1 2024 | 196 | 265M | 92.7% | 38 / 90 | 42 / 20 | 44M | 35M |
| Q4 2023 | 179 | 256M | 89.7% | 31 / 64 | 65 / 19 | 9M | 7M |
| Q3 2023 | 169 | 253M | 88.6% | 19 / 50 | 75 / 26 | 11M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
279 funds held SHC in Q2 2026, 58% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 9,083,154 | 3.18% | $161.23M | 0.13% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 8,614,655 | 3.02% | $152.91M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 6,215,762 | 2.18% | $110.33M | 0.06% | Jun 30, 2026 |
| Janus Henderson Contrarian Fund | 5,853,280 | 2.05% | $103.90M | 1.89% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 3,578,222 | 1.25% | $63.51M | 0.14% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 3,120,870 | 1.09% | $55.40M | 0.60% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 3,042,334 | 1.07% | $54.00M | 0.06% | Jun 30, 2026 |
| Fidelity Value Fund | 3,040,800 | 1.07% | $54.31M | 0.52% | Jul 31, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 1,803,810 | 0.63% | $32.02M | 0.30% | Jun 30, 2026 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 1,672,422 | 0.59% | $29.69M | 0.59% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 1,583,339 | 0.55% | $28.10M | 0.25% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 1,353,715 | 0.47% | $21.17M | 0.05% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 1,342,421 | 0.47% | $23.83M | 0.13% | Jun 30, 2026 |
| Schwab U.S. Small-Cap ETF | 1,272,915 | 0.45% | $19.91M | 0.09% | May 31, 2026 |
| iShares Russell Mid-Cap ETF | 1,146,698 | 0.40% | $20.35M | 0.04% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael B. Petras Jr. | Executive Chairman, Director | 4,367,305 | 1.53% | Aug 19, 2026 |
| Alton Shader | Chief Executive Officer, Director | 579,573 | 0.20% | May 27, 2026 |
| Michael P. Rutz | President of Sterigenics | 334,279 | 0.12% | Aug 11, 2026 |
| Jonathan M. Lyons | Sr. Vice President, CFO | 217,304 | 0.08% | Aug 7, 2026 |
| Erika Ostrowski | SVP, General Counsel and Sec. | 57,538 | 0.02% | Apr 8, 2026 |
| Alexander Dimitrief | Former SVP, GC and Sec. | 312,040 | 0.11% | Apr 2, 2026 |
| Kenneth D. Krause | Director | 14,970 | 0.01% | May 27, 2026 |
| David E. Wheadon | Director | 89,882 | 0.03% | May 27, 2026 |
| Richard G. Kyle | Director | 14,970 | 0.01% | May 27, 2026 |
| Vincent K. Petrella | Director | 95,751 | 0.03% | May 27, 2026 |
| James Neary | Director | 95,751 | 0.03% | May 27, 2026 |
| Karen Flynn | Director | 54,191 | 0.02% | May 27, 2026 |
| Simon, Christopher | Director | 34,102 | 0.01% | May 27, 2026 |
| Ann R. Klee | Director | 140,926 | 0.05% | May 27, 2026 |
| Sean Laurence Cunningham | Director | 95,751 | 0.03% | May 27, 2026 |
| Ruoxi Chen | Director | 95,751 | 0.03% | May 27, 2026 |
| Pincus (Bermuda) Private Equity GP Ltd. Warburg | Director, 10% owner | 118,929,897 | 41.67% | May 15, 2026 |
| Co-Invest Xi Lp Gtcr | Director, 10% owner | 12,735,301 | 4.46% | May 15, 2026 |
| Investment Xi Llc Gtcr | Director, 10% owner | 41,215,301 | 14.44% | May 15, 2026 |
| Partners Xi/A&c Lp Gtcr | Director, 10% owner | 49,215,301 | 17.25% | May 15, 2026 |
| Fund Xi/C Lp Gtcr | Director, 10% owner | 0 | – | May 15, 2026 |
| Warburg Pincus Partners II (Cayman), L.P. | Director, 10% owner | – | – | May 15, 2026 |
| Holdco L.P. Bull | Director, 10% owner | 73,822,952 | 25.87% | May 15, 2026 |
| Pincus Llc Warburg | Director, 10% owner | 34,102,952 | 11.95% | May 15, 2026 |
| Pincus & Co. Warburg | Director, 10% owner | 61,822,952 | 21.66% | May 15, 2026 |
| Warburg Pincus (Cayman) XI, L.P. | Director, 10% owner | 0 | – | May 15, 2026 |
| Warburg Pincus XI-C, LLC | Director, 10% owner | 61,822,952 | 21.66% | May 15, 2026 |
| Warburg Pincus Partners II, L.P. | Director, 10% owner | 19,102,952 | 6.69% | May 15, 2026 |
| Co-Invest L.P. Bull | Director, 10% owner | 118,929,897 | 41.67% | May 15, 2026 |
| Warburg Pincus Private Equity XI, L.P. | Director, 10% owner | – | – | May 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael B. Petras Jr. Executive Chairman, Director | Aug 17, 2026 | Sale | −850,000 | $18.50 | $15.73M | 3,969,393 |
| Michael B. Petras Jr. Executive Chairman, Director | Aug 17, 2026 | Sale | −294,515 | $18.50 | $5.45M | 397,912 |
| Michael P. Rutz President of Sterigenics | Aug 7, 2026 | Sale | −150,000 | $18.84 | $2.83M | 334,279 |
| Jonathan M. Lyons Sr. Vice President, CFO | Aug 5, 2026 | Tax withholding | −11,316 | $17.98 | $203.46K | 217,304 |
| Alton Shader Chief Executive Officer, Director | May 26, 2026 | Award | +203,634 | – | – | 579,573 |
| Alton Shader Chief Executive Officer, Director | May 26, 2026 | Award | +375,939 | – | – | 375,939 |
| David E. Wheadon Director | May 22, 2026 | Award | +14,970 | – | – | 89,882 |
| Simon, Christopher Director | May 22, 2026 | Award | +14,970 | – | – | 34,102 |
| Richard G. Kyle Director | May 22, 2026 | Award | +14,970 | – | – | 14,970 |
| Ruoxi Chen Director | May 22, 2026 | Award | +14,970 | – | – | 95,751 |
| Karen Flynn Director | May 22, 2026 | Award | +14,970 | – | – | 54,191 |
| Sean Laurence Cunningham Director | May 22, 2026 | Award | +14,970 | – | – | 95,751 |
| James Neary Director | May 22, 2026 | Award | +14,970 | – | – | 95,751 |
| Vincent K. Petrella Director | May 22, 2026 | Award | +14,970 | – | – | 95,751 |
| Kenneth D. Krause Director | May 22, 2026 | Award | +14,970 | – | – | 14,970 |
| Ann R. Klee Director | May 22, 2026 | Award | +14,970 | – | – | 140,926 |
| Warburg Pincus XI, L.P. Director, 10% owner | May 13, 2026 | Sale | −19,102,952 | $15.17 | $289.79M | 0 |
| Fund Xi/C Lp Gtcr Director, 10% owner | May 13, 2026 | Sale | −12,735,301 | $15.17 | $193.19M | 0 |
| Warburg Pincus (Cayman) XI, L.P. Director, 10% owner | May 13, 2026 | Sale | −19,102,952 | $15.17 | $289.79M | 0 |
| Alexander Dimitrief Former SVP, GC and Sec. | Mar 31, 2026 | Tax withholding | −7,941 | $14.34 | $113.87K | 312,040 |
| Co-Invest Xi Lp Gtcr Director, 10% owner | Mar 6, 2026 | Sale | −10,000,000 | $15.27 | $152.70M | 12,735,301 |
| Pincus Partners GP LLC Warburg Director, 10% owner | Mar 6, 2026 | Sale | −15,000,000 | $15.27 | $229.05M | 19,102,952 |
| Warburg Pincus Partners II, L.P. Director, 10% owner | Mar 6, 2026 | Sale | −15,000,000 | $15.27 | $229.05M | 19,102,952 |
| Jonathan M. Lyons Sr. Vice President, CFO | Mar 2, 2026 | Tax withholding | −23,988 | $15.91 | $381.65K | 177,505 |
| Jonathan M. Lyons Sr. Vice President, CFO | Mar 2, 2026 | Tax withholding | −8,240 | $15.91 | $131.10K | 169,265 |
| Jonathan M. Lyons Sr. Vice President, CFO | Mar 2, 2026 | Award | +59,355 | – | – | 228,620 |
| Jonathan M. Lyons Sr. Vice President, CFO | Mar 2, 2026 | Option exercise | +17,937 | – | – | 201,493 |
| Jonathan M. Lyons Sr. Vice President, CFO | Mar 2, 2026 | Tax withholding | −6,046 | $15.91 | $96.19K | 183,556 |
| Michael B. Petras Jr. Chairman & CEO, Director | Mar 2, 2026 | Option exercise | +89,686 | – | – | 570,835 |
| Michael B. Petras Jr. Chairman & CEO, Director | Mar 2, 2026 | Tax withholding | −79,104 | $15.91 | $1.26M | 452,179 |
| Michael B. Petras Jr. Chairman & CEO, Director | Mar 2, 2026 | Tax withholding | −39,552 | $15.91 | $629.27K | 531,283 |
| Michael B. Petras Jr. Chairman & CEO, Director | Mar 2, 2026 | Award | +240,248 | – | – | 692,427 |
| Michael B. Petras Jr. Chairman & CEO, Director | Mar 2, 2026 | Tax withholding | −40,302 | $15.91 | $641.20K | 481,149 |
| Michael B. Petras Jr. Chairman & CEO, Director | Mar 2, 2026 | Tax withholding | −31,339 | $15.91 | $498.60K | 521,451 |
| Alexander Dimitrief SVP, General Counsel and Sec. | Mar 2, 2026 | Option exercise | +16,816 | – | – | 343,600 |
| Alexander Dimitrief SVP, General Counsel and Sec. | Mar 2, 2026 | Tax withholding | −23,619 | $15.91 | $375.78K | 319,981 |
| Alexander Dimitrief SVP, General Counsel and Sec. | Mar 2, 2026 | Tax withholding | −7,941 | $15.91 | $126.34K | 326,784 |
| Michael P. Rutz President of Sterigenics | Mar 2, 2026 | Tax withholding | −4,495 | $15.91 | $71.52K | 441,980 |
| Michael P. Rutz President of Sterigenics | Mar 2, 2026 | Tax withholding | −3,729 | $15.91 | $59.33K | 446,475 |
| Michael P. Rutz President of Sterigenics | Mar 2, 2026 | Option exercise | +14,573 | – | – | 456,553 |
| Michael P. Rutz President of Sterigenics | Mar 2, 2026 | Tax withholding | −17,497 | $15.91 | $278.38K | 439,056 |
| Michael P. Rutz President of Sterigenics | Mar 2, 2026 | Award | +45,223 | – | – | 484,279 |
| Michael B. Petras Jr. Chairman & CEO, Director | Dec 8, 2025 | Sale | −39,243 | $16.45 | $645.55K | 0 |
| Michael B. Petras Jr. Chairman & CEO, Director | Dec 8, 2025 | Sale | −394,861 | $16.45 | $6.50M | 4,819,393 |
| Michael B. Petras Jr. Chairman & CEO, Director | Dec 8, 2025 | Sale | −315,896 | $16.45 | $5.20M | 552,790 |
| Fund Xi/A Lp Gtcr Director, 10% owner | Dec 3, 2025 | Sale | −6,480,000 | $16.33 | $105.82M | 22,735,301 |
| Pincus Llc Warburg Director, 10% owner | Dec 3, 2025 | Sale | −9,720,000 | $16.33 | $158.73M | 34,102,952 |
| Pincus Partners GP LLC Warburg Director, 10% owner | Dec 3, 2025 | Sale | −9,720,000 | $16.33 | $158.73M | 34,102,952 |
| Warburg Pincus Private Equity XI-C, L.P. Director, 10% owner | Nov 10, 2025 | Sale | −18,000,000 | $15.65 | $281.70M | 43,822,952 |
| Fund Xi/A Lp Gtcr Director, 10% owner | Nov 10, 2025 | Sale | −12,000,000 | $15.65 | $187.80M | 29,215,301 |
| Warburg Pincus Partners II, L.P. Director | Nov 10, 2025 | Sale | −18,000,000 | $15.65 | $281.70M | 43,822,952 |
| Warburg Pincus XI-C, LLC Director, 10% owner | Sep 5, 2025 | Sale | −12,000,000 | $15.11 | $181.32M | 61,822,952 |
| Pincus & Co. Warburg Director, 10% owner | Sep 5, 2025 | Sale | −12,000,000 | $15.11 | $181.32M | 61,822,952 |
| Investment Xi Llc Gtcr Director, 10% owner | Sep 5, 2025 | Sale | −8,000,000 | $15.11 | $120.88M | 41,215,301 |
| Michael P. Rutz President of Sterigenics | Aug 22, 2025 | Sale | −126,611 | $16.38 | $2.07M | 450,204 |
| Jonathan M. Lyons Sr. Vice President, CFO | Aug 5, 2025 | Tax withholding | −11,508 | $11.19 | $128.77K | 189,602 |
| Karen Flynn Director | May 22, 2025 | Award | +19,132 | – | – | 39,221 |
| Simon, Christopher Director | May 22, 2025 | Award | +19,132 | – | – | 19,132 |
| David E. Wheadon Director | May 22, 2025 | Award | +19,132 | – | – | 74,912 |
| Sean Laurence Cunningham Director | May 22, 2025 | Award | +19,132 | – | – | 80,781 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sotera Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,939 shares on Sep 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Michael B. Petras Jr. Chairman, CEO | Aug 17, 2026 | 1,144,515 | $21.62M | Aug 17, 2026 | Executive Compensation |
| Michael P. Rutz Officer | Aug 7, 2026 | 150,000 | $2.84M | Aug 7, 2026 | RSU Vesting |
| Michael B. Petras Jr. Chairman, CEO | Dec 8, 2025 | 750,000 | $12.56M | Dec 8, 2025 | Compensation |
| Fund Xi/A Lp Gtcr Owner | Dec 4, 2025 | 1,295,747 | $21.16M | Dec 3, 2025 | Pre-IPO Organization |
| Pincus Llc Warburg Affiliate | Dec 3, 2025 | 9,720,000 | $163.68M | Dec 3, 2025 | Private Placement - From Issuer |
| Fund Xi/A Lp Gtcr Owner | Dec 3, 2025 | 5,143,033 | $83.99M | Dec 3, 2025 | Pre-IPO Organization |
| Co-Invest Xi Lp Gtcr Owner | Dec 3, 2025 | 41,219 | $673.11K | Dec 3, 2025 | Pre-IPO Organization |
| Michael P. Rutz Officer | Aug 22, 2025 | 126,611 | $2.04M | Aug 22, 2025 | Equity Compensation |
See a number that looks wrong?